|
Index of reports
> Cases with Vomiting (60)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Sandostatin (Octreotide) where reactions include vomiting. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 60 Next >>
Possible Sandostatin side effects in male
Reported by a consumer/non-health professional from Canada on 2012-08-27
Patient: male
Reactions: Abdominal Pain, Productive Cough, Pruritus, Nasopharyngitis, Metastases To Liver, Pyrexia, Faecal Volume Increased, Hot Flush, Fatigue, Cough, Decreased Appetite, Abdominal Pain Lower, Vomiting, Pain in Extremity, Nausea, Abnormal Faeces, Injection Site Pain, Skin Plaque, Flushing, Abdominal Mass, Arthralgia, Gastrointestinal Neoplasm, Diarrhoea, Dysphonia, Neoplasm Malignant, Visual Impairment, Vision Blurred, Lacrimation Increased, Depressed Mood
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2010-03-13
Sandostatin LAR
Dosage: 40 mg, every 4 weeks
Sandostatin
Dosage: 100 ug, tid
Start date: 2010-03-01
Sandostatin LAR
Dosage: 30 mg every 4 weeks
Sandostatin
Indication: Neuroendocrine Tumour
End date: 2008-01-01
Other drugs received by patient: Antibiotics; Morphine
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-08-03
Patient: male
Reactions: Abdominal Pain, Nasopharyngitis, Pruritus, Metastases To Liver, Faecal Volume Increased, Fatigue, Hot Flush, Decreased Appetite, Abdominal Pain Lower, Vomiting, Nausea, Pain in Extremity, Abnormal Faeces, Injection Site Pain, Skin Plaque, Flushing, Abdominal Mass, Diarrhoea, Gastrointestinal Neoplasm, Neoplasm Malignant, Dysphonia, Arthralgia, Visual Impairment, Vision Blurred, Lacrimation Increased, Depressed Mood
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 40 mg, every 4 weeks
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2010-03-13
Sandostatin
Dosage: 100 ug, tid
Start date: 2010-03-01
Sandostatin
Indication: Neuroendocrine Tumour
End date: 2008-01-01
Sandostatin LAR
Dosage: 30 mg every 4 weeks
Other drugs received by patient: Morphine Sulfate
Possible Sandostatin side effects in female
Reported by a physician from Canada on 2012-08-01
Patient: female
Reactions: Haemorrhage, Rectal Haemorrhage, Malaise, Fatigue, White Blood Cell Count Increased, Lethargy, Vomiting, Loss of Control of Legs, Nausea, Urinary Tract Infection, Injection Site Pain, Facial Pain, Blood Creatine Increased, Tremor, Discomfort, Haemoglobin Decreased, Diarrhoea, Liver Abscess, Blood Pressure Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Indication: Carcinoid Tumour
Sandostatin LAR
Dosage: 20 mg, every 4 weeks
Start date: 2011-07-05
Sandostatin LAR
Dosage: 20 mg, qmo
Indication: Carcinoid Tumour
Start date: 2011-07-05
Other drugs received by patient: Norfloxacin
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-07-31
Patient: female
Reactions: Labyrinthitis, Vomiting, Nausea, Dizziness, Vertigo, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 50 ug, unk
Indication: Acromegaly
Sandostatin LAR
Dosage: 20 mg every 4 weeks
Indication: Acromegaly
Start date: 2011-07-29
End date: 2011-07-29
Other drugs received by patient: Humalog; Synthroid; Lanreotide; Humalin
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-07-31
Patient: male
Reactions: Vomiting, Nausea, Flank Pain, Gastric Disorder, Hyperhidrosis, Ascites
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Pancreatitis Chronic
Start date: 2011-12-12
Sandostatin
Dosage: 100 ug
Indication: Pancreatitis Chronic
Start date: 2011-12-02
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-07-17
Patient: female
Reactions: Abdominal Pain, Flatulence, Pain, Constipation, Fall, Abdominal Pain Upper, Herpes Zoster, Fatigue, Malaise, Dizziness, Abdominal Distension, Anuria, Blood Pressure Increased, Back Pain, Humerus Fracture, Gastrointestinal Motility Disorder, Vomiting, Pain in Extremity, Nausea, Flushing, Arthralgia, Diarrhoea, Ocular Hyperaemia, Flank Pain, Vision Blurred, Asthenia, Neuralgia, Abdominal Adhesions
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg, qmo
Sandostatin
Dosage: 100 ug, tid
Indication: Small Intestine Carcinoma
Sandostatin LAR
Dosage: 30 mg, qmo
Sandostatin LAR
Dosage: 30 mg, tiw
Indication: Small Intestine Carcinoma
Start date: 2009-05-26
Sandostatin LAR
Dosage: 30 mg, tiw
Sandostatin LAR
Dosage: 30 mg, tiw
Other drugs received by patient: Xeloda; Capecitabine
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from United States on 2012-06-27
Patient: female
Reactions: Malaise, Vomiting, Nausea, Dyspepsia, Haemorrhoids, Constipation, Anal Fissure
Drug(s) suspected as cause:
Citrate Magnesia
Dosage: unk
Sandostatin
Dosage: unk
Somavert
Dosage: unk
Possible Sandostatin side effects in male
Reported by a consumer/non-health professional from Canada on 2012-06-22
Patient: male
Reactions: Abdominal Pain, Headache, Erythema, Oedema Peripheral, Blood Pressure Abnormal, Nervousness, Blood Pressure Systolic Decreased, Chest Discomfort, Cardiac Murmur, Blood Urine Present, Pain in Extremity, Hypoaesthesia, Tremor, Carcinoid Tumour of THE Pancreas, Flushing, Heart Rate Decreased, Vision Blurred, Fall, Abdominal Pain Upper, Hepatomegaly, Chest Pain, Dizziness, Heart Rate Irregular, Dyspnoea, Vomiting, Nausea, Retching, Lung Neoplasm, Burning Sensation, Diarrhoea, Heart Rate Increased, Visual Impairment, Hypertension, Blood Pressure Fluctuation, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg, every 3 weeks
Sandostatin LAR
Dosage: 30 mg, every 3 weeks
Start date: 2010-08-25
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Small Intestine Carcinoma
Start date: 2010-08-22
Sandostatin
Dosage: 5 ug, tid
Indication: Carcinoid Tumour of THE Small Bowel
Start date: 2010-04-22
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Other drugs received by patient: Propranolol; Lyrica; Codeine; Lantus; Rasilez D; Ranitidine
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-06-19
Patient: male
Reactions: Abdominal Pain, Headache, Erythema, Oedema Peripheral, Blood Pressure Abnormal, Nervousness, Blood Pressure Systolic Decreased, Chest Discomfort, Blood Urine Present, Cardiac Murmur, Pain in Extremity, Hypoaesthesia, Flushing, Heart Rate Decreased, Vision Blurred, Fall, Abdominal Pain Upper, Hepatomegaly, Chest Pain, Dizziness, Heart Rate Irregular, Vomiting, Dyspnoea, Retching, Nausea, Lung Neoplasm, Burning Sensation, Diarrhoea, Heart Rate Increased, Visual Impairment, Asthenia, Blood Pressure Fluctuation, Hypertension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg, every 3 weeks
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Small Intestine Carcinoma
Start date: 2010-08-22
Sandostatin
Dosage: 5 ug, tid
Indication: Carcinoid Tumour of THE Small Bowel
Start date: 2010-04-22
Sandostatin LAR
Dosage: 30 mg, every 3 weeks
Start date: 2010-08-25
Other drugs received by patient: Propranolol; Lyrica; Lantus; Rasilez D; Codeine; Ranitidine
Possible Sandostatin side effects in male
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-06-11
Patient: male
Reactions: Bowel Movement Irregularity, Vomiting, Flatulence, Pain, Thirst Decreased, Death, Diarrhoea, Gait Disturbance, Blood Glucose Fluctuation, Asthenia, Hypersomnia, Lethargy, Decreased Appetite
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 100 ug, once
Indication: Neuroendocrine Tumour
Start date: 2012-01-13
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Neuroendocrine Carcinoma
Start date: 2012-01-24
End date: 2012-05-16
Other drugs received by patient: Morphine
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-06-01
Patient: male
Reactions: Abdominal Pain, Pruritus, Metastases To Liver, Faecal Volume Increased, Fatigue, Hot Flush, Decreased Appetite, Abdominal Pain Lower, Vomiting, Nausea, Pain in Extremity, Abnormal Faeces, Injection Site Pain, Skin Plaque, Flushing, Abdominal Mass, Arthralgia, Neoplasm Malignant, Dysphonia, Gastrointestinal Neoplasm, Diarrhoea, Visual Impairment, Vision Blurred, Lacrimation Increased, Depressed Mood
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg every 4 weeks
Sandostatin
Dosage: 100 ug, tid
Start date: 2010-03-01
Sandostatin LAR
Dosage: 40 mg, every 4 weeks
Sandostatin
Indication: Neuroendocrine Tumour
End date: 2008-01-01
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2010-03-13
Other drugs received by patient: Morphine
Possible Sandostatin side effects in male
Reported by a consumer/non-health professional from United States on 2012-05-25
Patient: male, weighing 56.0 kg (123.2 pounds)
Reactions: Bedridden, Vomiting, Nausea, Cholangitis, Gastrinoma, Constipation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 0.1 mg, unk
Indication: Pancreatic Carcinoma
Sandostatin
Dosage: 0.03 mg, unk
Other drugs received by patient: Afinitor
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-05-25
Patient: male
Reactions: Abdominal Pain, Headache, Fall, Erythema, Abdominal Pain Upper, Hepatomegaly, Chest Pain, Oedema Peripheral, Dizziness, Heart Rate Irregular, Blood Pressure Abnormal, Nervousness, Blood Pressure Systolic Decreased, Blood Urine Present, Vomiting, Chest Discomfort, Dyspnoea, Cardiac Murmur, Pain in Extremity, Nausea, Retching, Lung Neoplasm, Hypoaesthesia, Burning Sensation, Flushing, Heart Rate Decreased, Diarrhoea, Heart Rate Increased, Vision Blurred, Hypertension, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 5 ug, tid
Indication: Carcinoid Tumour of THE Small Bowel
Start date: 2010-04-22
Sandostatin LAR
Dosage: 30 mg, every 3 weeks
Start date: 2010-08-25
Sandostatin LAR
Dosage: 30 mg, every 3 weeks
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Small Intestine Carcinoma
Start date: 2010-08-22
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Other drugs received by patient: Propranolol; Codeine Sulfate; Lantus; Rasilez D; Lyrica; Ranitidine
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from United States on 2012-05-24
Patient: female
Reactions: Vomiting, Pain, Headache, Intracranial Pressure Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Other drugs received by patient: Verapamil; Nascobal
Possible Sandostatin side effects in male
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-05-23
Patient: male
Reactions: Bowel Movement Irregularity, Vomiting, Flatulence, Pain, Thirst Decreased, Diarrhoea, Blood Glucose Fluctuation, Gait Disturbance, Asthenia, Hypersomnia, Lethargy, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 100 ug, once
Indication: Neuroendocrine Tumour
Start date: 2012-01-13
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Neuroendocrine Carcinoma
Start date: 2012-01-24
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Other drugs received by patient: Morphine
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-05-22
Patient: male
Reactions: Bowel Movement Irregularity, Vomiting, Flatulence, Pain, Thirst Decreased, Diarrhoea, Blood Glucose Fluctuation, Hypersomnia, Decreased Appetite, Lethargy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Neuroendocrine Carcinoma
Start date: 2012-01-24
Sandostatin
Dosage: 100 ug, once
Indication: Neuroendocrine Tumour
Start date: 2012-01-13
Other drugs received by patient: Morphine
Possible Sandostatin side effects in 57 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-05-16
Patient: 57 year old female
Reactions: Therapeutic Response Decreased, Death, Vomiting, Neoplasm Malignant, Malignant Ascites, Abdominal Distension, General Physical Health Deterioration, Intestinal Obstruction
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: unk ukn, unk
Sandostatin
Dosage: unk ukn, unk
Indication: Intestinal Obstruction
Other drugs received by patient: TPN
Possible Sandostatin side effects in female
Reported by a physician from Canada on 2012-05-14
Patient: female
Reactions: Abdominal Pain, Flatulence, Pain, Constipation, Fall, Abdominal Pain Upper, Herpes Zoster, Fatigue, Malaise, Abdominal Distension, Dizziness, Back Pain, Blood Pressure Increased, Humerus Fracture, Vomiting, Nausea, Pain in Extremity, Flushing, Diarrhoea, Arthralgia, Ocular Hyperaemia, Flank Pain, Vision Blurred, Asthenia, Neuralgia, Abdominal Adhesions
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg, qmo
Sandostatin LAR
Dosage: 30 mg, every 3 weeks
Sandostatin LAR
Dosage: 30 mg, qmo
Sandostatin
Dosage: 100 ug, tid
Indication: Small Intestine Carcinoma
Sandostatin LAR
Dosage: 30 mg, tiw
Indication: Small Intestine Carcinoma
Start date: 2009-05-26
Sandostatin LAR
Dosage: 30 mg, every three weeks
Other drugs received by patient: Xeloda; Capecitabine
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-05-09
Patient: male
Reactions: Weight Decreased, Abdominal Pain, Nasopharyngitis, Mouth Ulceration, Skin Burning Sensation, Oropharyngeal Pain, Erythema, Gastritis, Haematemesis, Abdominal Discomfort, Hot Flush, Fatigue, Injection Site Induration, Decreased Appetite, Cough, Injection Site Mass, Vomiting, Stomatitis, Nausea, Injection Site Pain, Diarrhoea, Hypophagia, Rash Maculo-Papular, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 40 mg, every three weeks
End date: 2011-06-08
Sandostatin
Dosage: 500 ug, bid
Start date: 2011-08-25
Sandostatin LAR
Dosage: 30 mg, tiw
Sandostatin LAR
Dosage: 40 mg every three weeks
End date: 2011-05-21
Sandostatin
Dosage: 150 ug, bid
Start date: 2011-02-14
End date: 2011-02-17
Sandostatin
Dosage: 250 ug, bid
Start date: 2011-06-08
Sandostatin
Dosage: 500 ug, bid
Start date: 2011-08-25
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Indication: Neuroendocrine Tumour
Start date: 2009-09-10
Sandostatin LAR
Dosage: 40 mg, every 4 weeks
Sandostatin LAR
Dosage: 40 mg, qmo
Sandostatin
Dosage: 100 ug, tid
Indication: Neuroendocrine Tumour
Start date: 2011-02-01
End date: 2011-02-14
Sandostatin
Dosage: 500 ug, tid
Other drugs received by patient: Mesalamine; Insulin; Aspirin; Gravol TAB; Fragmin; Pantoprazole Sodium
Possible Sandostatin side effects in male
Reported by a physician from United States on 2012-05-07
Patient: male
Reactions: Bedridden, Vomiting, Nausea, Constipation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 0.03 mg, unk
Sandostatin
Dosage: 0.1 mg, unk
Indication: Neuroendocrine Tumour
Other drugs received by patient: Afinitor
Possible Sandostatin side effects in female
Reported by a pharmacist from Canada on 2012-04-30
Patient: female
Reactions: Pruritus, Sciatica, Headache, Frequent Bowel Movements, non-Hodgkin's Lymphoma Recurrent, Sinusitis, Blood Glucose Increased, Vomiting, Pain in Extremity, Musculoskeletal Pain, Anaemia, Haemorrhoids, Blood Glucose Decreased, Neoplasm Malignant, Diarrhoea, Bronchitis, Influenza Like Illness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 20 mg, every 4 weeks
Sandostatin LAR
Dosage: 20 mg, qmo
Sandostatin LAR
Dosage: 20 mg, qmo
Indication: Post Gastric Surgery Syndrome
Start date: 2009-12-15
Sandostatin LAR
Dosage: 20 mg, qmo
Sandostatin LAR
Dosage: 20 mg, every 4 weeks
Start date: 2010-07-12
Sandostatin
Dosage: unk ukn, bid
Possible Sandostatin side effects in male
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-04-06
Patient: male
Reactions: Abdominal Pain, Pruritus, Metastases To Liver, Faecal Volume Increased, Hot Flush, Fatigue, Decreased Appetite, Abdominal Pain Lower, Vomiting, Pain in Extremity, Nausea, Abnormal Faeces, Injection Site Pain, Skin Plaque, Flushing, Abdominal Mass, Gastrointestinal Neoplasm, Dysphonia, Neoplasm Malignant, Arthralgia, Diarrhoea, Visual Impairment, Vision Blurred, Lacrimation Increased, Depressed Mood
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2010-03-13
Sandostatin LAR
Dosage: 40 mg, every 4 weeks
Sandostatin LAR
Dosage: 30 mg every 4 weeks
Sandostatin
Dosage: 100 ug, tid
Start date: 2010-03-01
Sandostatin
Indication: Neuroendocrine Tumour
End date: 2008-01-01
Other drugs received by patient: Morphine
Possible Sandostatin side effects in female
Reported by a physician from Canada on 2012-04-05
Patient: female
Reactions: Abdominal Pain, Pedal Pulse Abnormal, Loss of Consciousness, Malaise, Psychiatric Symptom, Epistaxis, Back Pain, Visual Field Defect, Pain in Extremity, Anaemia, Hypotension, General Physical Health Deterioration, Stress, Abdominal Pain Upper, Speech Disorder, Myalgia, Fatigue, Transient Ischaemic Attack, Blood Sodium Decreased, Blood Pressure Increased, Vomiting, Nausea, Muscular Weakness, Injection Site Pain, Cerebrovascular Accident, Diarrhoea, Arthralgia, Hypophagia, Memory Impairment, Gait Disturbance, Asthenia, Feeling Abnormal, Influenza
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 20 mg, every 3 weeks
Start date: 2010-06-02
Sandostatin
Dosage: 20 mg, bid
Sandostatin LAR
Dosage: 20 mg, qmo
End date: 2011-04-05
Sandostatin LAR
Dosage: 20 mg, every 4 weeks
Indication: Neuroendocrine Tumour
Start date: 2007-08-24
End date: 2011-04-05
Sandostatin
Indication: Neuroendocrine Tumour
Other drugs received by patient: Ferrous Sulfate TAB; Calcium with Vitamin D; Swine FLU Vaccine, Monovalent; Asaphen; Novo-Venlafaxine; Metformin HCL; Novo-Loperamide; Cyproheptadine HCL; Senntab; Novo-Pantoprazole; Novo-Docusate; Synthroid; Oxazepam
Possible Sandostatin side effects in female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-04
Patient: female, weighing 45.0 kg (99.0 pounds)
Reactions: Abdominal Pain, Tumour Necrosis, Drug Ineffective, Disseminated Intravascular Coagulation, Multi-Organ Failure, Haematocrit Decreased, Circulatory Collapse, Blood Creatinine Increased, Decreased Appetite, White Blood Cell Count Increased, Renal Failure Acute, Cardiac Failure Congestive, Dyspnoea, Blood Urea Increased, Vomiting, Blood Potassium Increased, Haemoglobin Decreased, Neoplasm Malignant, Diarrhoea, Oliguria, Dehydration, Depressed Level of Consciousness, Platelet Count Decreased, Blood Pressure Decreased
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 50 ug/d
Start date: 2004-07-20
End date: 2004-07-22
Sandostatin
Dosage: 100 ug/d
Start date: 2004-08-08
End date: 2004-08-11
Sandostatin
Dosage: 50 ug, tid
Start date: 2004-06-30
End date: 2004-07-12
Sandostatin
Dosage: 50 ug, 6qd
Start date: 2004-07-25
End date: 2004-08-07
Sandostatin
Dosage: 200 ug/day
Start date: 2004-08-12
End date: 2005-03-01
Sandostatin
Dosage: 100 ug/d
Indication: Vipoma
Start date: 2004-03-31
End date: 2004-06-29
Sandostatin
Dosage: 50 ug, bid
Start date: 2004-07-13
End date: 2004-07-19
Sandostatin
Dosage: 300 ug daily
Sandostatin LAR
Dosage: 20 mg
Indication: Vipoma
Start date: 2004-07-07
End date: 2004-07-07
Sandostatin
Dosage: 50 ug, tid
Start date: 2004-07-23
End date: 2004-07-24
Other drugs received by patient: Lansoprazole
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-03-29
Patient: male
Reactions: Abdominal Pain, Pruritus, Metastases To Liver, Faecal Volume Increased, Fatigue, Hot Flush, Decreased Appetite, Abdominal Pain Lower, Vomiting, Pain in Extremity, Nausea, Abnormal Faeces, Injection Site Pain, Skin Plaque, Flushing, Abdominal Mass, Arthralgia, Diarrhoea, Gastrointestinal Neoplasm, Dysphonia, Neoplasm Malignant, Visual Impairment, Vision Blurred, Lacrimation Increased, Depressed Mood
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 40 mg, every 4 weeks
Sandostatin
Indication: Neuroendocrine Tumour
End date: 2008-01-01
Sandostatin
Dosage: 100 ug, tid
Start date: 2010-03-01
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2010-03-13
Sandostatin LAR
Dosage: 30 mg every 4 weeks
Other drugs received by patient: Morphine
Possible Sandostatin side effects in female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-03-29
Patient: female, weighing 45.0 kg (99.0 pounds)
Reactions: Tumour Necrosis, Abdominal Pain, Drug Ineffective, Disseminated Intravascular Coagulation, Multi-Organ Failure, Haematocrit Decreased, Circulatory Collapse, Blood Creatinine Increased, Renal Failure Acute, Decreased Appetite, White Blood Cell Count Increased, Cardiac Failure Congestive, Vomiting, Dyspnoea, Blood Urea Increased, Blood Potassium Increased, Haemoglobin Decreased, Neoplasm Malignant, Diarrhoea, Oliguria, Dehydration, Depressed Level of Consciousness, Platelet Count Decreased, Blood Pressure Decreased
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 20 mg
Indication: Vipoma
Start date: 2004-07-07
End date: 2004-07-07
Sandostatin
Dosage: 50 ug, 6qd
Start date: 2004-07-25
End date: 2004-08-07
Sandostatin
Dosage: 50 ug, tid
Start date: 2004-06-30
End date: 2004-07-12
Sandostatin
Dosage: 50 ug/d
Start date: 2004-07-20
End date: 2004-07-22
Sandostatin
Dosage: 200 ug/day
Start date: 2004-08-12
End date: 2005-03-01
Sandostatin
Dosage: 50 ug, bid
Start date: 2004-07-13
End date: 2004-07-19
Sandostatin
Dosage: 300 ug, unk
Sandostatin
Dosage: 100 ug/d
Indication: Vipoma
Start date: 2004-03-31
End date: 2004-06-29
Sandostatin
Dosage: 50 ug, tid
Start date: 2004-07-23
End date: 2004-07-24
Sandostatin
Dosage: 100 ug/d
Start date: 2004-08-08
End date: 2004-08-11
Other drugs received by patient: Lansoprazole
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-03-22
Patient: female
Reactions: Pruritus, Sciatica, Hypoglycaemia, Headache, Blood Glucose Abnormal, Frequent Bowel Movements, non-Hodgkin's Lymphoma Recurrent, Sinusitis, Vomiting, Pain in Extremity, Musculoskeletal Pain, Anaemia, Haemorrhoids, Neoplasm Malignant, Diarrhoea, Bronchitis, Influenza Like Illness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 20 mg, every 4 weeks
Sandostatin
Sandostatin LAR
Dosage: 20 mg, every 4 weeks
Start date: 2010-07-12
Sandostatin LAR
Dosage: 20 mg, qmo
Indication: Post Gastric Surgery Syndrome
Start date: 2009-12-15
Sandostatin LAR
Dosage: 20 mg, qmo
Sandostatin LAR
Dosage: 20 mg, qmo
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-03-16
Patient: male
Reactions: Abdominal Pain, Pruritus, Metastases To Liver, Faecal Volume Increased, Hot Flush, Fatigue, Decreased Appetite, Abdominal Pain Lower, Vomiting, Nausea, Pain in Extremity, Abnormal Faeces, Injection Site Pain, Skin Plaque, Flushing, Abdominal Mass, Neoplasm Malignant, Diarrhoea, Arthralgia, Dysphonia, Gastrointestinal Neoplasm, Visual Impairment, Vision Blurred, Lacrimation Increased, Depressed Mood
Drug(s) suspected as cause:
Sandostatin
Dosage: 100 ug, tid
Start date: 2010-03-01
Sandostatin LAR
Dosage: 30 mg every 4 weeks
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2010-03-13
Sandostatin
Indication: Neuroendocrine Tumour
End date: 2008-01-01
Other drugs received by patient: Morphine
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-02-20
Patient: female
Reactions: Vomiting, Loss of Control of Legs, Nausea, Haemorrhage, Urinary Tract Infection, Rectal Haemorrhage, Injection Site Pain, Blood Creatine Increased, Facial Pain, Discomfort, Tremor, Haemoglobin Decreased, Malaise, Fatigue, Diarrhoea, Liver Abscess, Blood Pressure Decreased, White Blood Cell Count Increased, Lethargy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Indication: Carcinoid Tumour
Sandostatin LAR
Dosage: 20 mg, every 4 weeks
Start date: 2011-07-05
Sandostatin LAR
Dosage: 20 mg, qmo
Indication: Carcinoid Tumour
Start date: 2011-07-05
Other drugs received by patient: Norfloxacin
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-02-20
Patient: male
Reactions: Weight Decreased, Abdominal Pain, Nasopharyngitis, Mouth Ulceration, Skin Burning Sensation, Oropharyngeal Pain, Erythema, Haematemesis, Gastritis, Abdominal Discomfort, Hot Flush, Fatigue, Injection Site Induration, Decreased Appetite, Cough, Injection Site Mass, Stomatitis, Vomiting, Nausea, Injection Site Pain, Diarrhoea, Hypophagia, Rash Maculo-Papular, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 40 mg, every 4 weeks
Sandostatin LAR
Dosage: 40 mg, qmo
Sandostatin
Dosage: 500 ug, bid
Start date: 2011-08-25
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Indication: Neuroendocrine Tumour
Start date: 2009-09-10
Sandostatin LAR
Dosage: 40 mg every three weeks
End date: 2011-05-21
Sandostatin
Dosage: 100 ug, tid
Indication: Neuroendocrine Tumour
Start date: 2011-02-01
End date: 2011-02-14
Sandostatin
Dosage: 250 ug, bid
Start date: 2011-06-08
Sandostatin
Dosage: 150 ug, bid
Start date: 2011-02-14
End date: 2011-02-17
Sandostatin
Dosage: 500 ug, tid
Sandostatin
Dosage: 500 ug, bid
Start date: 2011-08-25
Sandostatin LAR
Dosage: 30 mg, tiw
Other drugs received by patient: Aspirin; Fragmin; Mesalamine; Insulin; Gravol TAB; Pantoprazole Sodium
Page 1 Next >>
|
